Pacs Group, Stock EBITDA
| PACS Stock | 13.35 0.42 3.25% |
PACS Group, fundamentals help investors to digest information that contributes to PACS Group,'s financial success or failures. It also enables traders to predict the movement of PACS Stock. The fundamental analysis module provides a way to measure PACS Group,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PACS Group, stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | 267.8 M | 210.9 M |
PACS | EBITDA |
PACS Group, Company EBITDA Analysis
PACS Group,'s EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current PACS Group, EBITDA | 232.87 M |
Most of PACS Group,'s fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PACS Group, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
PACS EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for PACS Group, is extremely important. It helps to project a fair market value of PACS Stock properly, considering its historical fundamentals such as EBITDA. Since PACS Group,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of PACS Group,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of PACS Group,'s interrelated accounts and indicators.
Click cells to compare fundamentals
PACS EBITDA Historical Pattern
Today, most investors in PACS Group, Stock are looking for potential investment opportunities by analyzing not only static indicators but also various PACS Group,'s growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's ebitda growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of PACS Group, ebitda as a starting point in their analysis.
PACS Group, EBITDA |
| Timeline |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
PACS Ebitda
Ebitda |
|
According to the company disclosure, PACS Group, reported earnings before interest,tax, depreciation and amortization of 232.87 M. This is 73.46% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The ebitda for all United States stocks is 94.03% higher than that of the company.
PACS EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PACS Group,'s direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PACS Group, could also be used in its relative valuation, which is a method of valuing PACS Group, by comparing valuation metrics of similar companies.PACS Group, is currently under evaluation in ebitda category among its peers.
PACS Fundamentals
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.0007 % | ||||
| Current Valuation | 8.92 B | ||||
| Shares Outstanding | 155.18 M | ||||
| Shares Owned By Insiders | 82.76 % | ||||
| Shares Owned By Institutions | 21.54 % | ||||
| Number Of Shares Shorted | 2.25 M | ||||
| Price To Book | 11.04 X | ||||
| Price To Sales | 1.78 X | ||||
| Revenue | 3.11 B | ||||
| EBITDA | 232.87 M | ||||
| Net Income | 112.87 M | ||||
| Total Debt | 2.85 B | ||||
| Book Value Per Share | 3.75 X | ||||
| Cash Flow From Operations | 63.7 M | ||||
| Short Ratio | 7.61 X | ||||
| Earnings Per Share | 0.61 X | ||||
| Price To Earnings To Growth | 1.43 X | ||||
| Target Price | 41.0 | ||||
| Number Of Employees | 32.43 K | ||||
| Market Capitalization | 6.32 B | ||||
| Total Asset | 3.51 B | ||||
| Retained Earnings | 96.12 M | ||||
| Working Capital | 265.22 M | ||||
| Net Asset | 3.51 B |
About PACS Group, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PACS Group,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PACS Group, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PACS Group, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for PACS Stock Analysis
When running PACS Group,'s price analysis, check to measure PACS Group,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PACS Group, is operating at the current time. Most of PACS Group,'s value examination focuses on studying past and present price action to predict the probability of PACS Group,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PACS Group,'s price. Additionally, you may evaluate how the addition of PACS Group, to your portfolios can decrease your overall portfolio volatility.